Analysis and Evaluation of China Annual Major Medical Innovation 2022: A Mix‐ Method Approach Study
Background: The selection of China annual major medical innovation organized by Chinese Academy of Medical Sciences (CAMS) has attracted increasing attention from the Chinese government and all sectors of society. It aims to explore a classification evaluation system that can reflect the characteris...
Saved in:
| Main Authors: | , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
KeAi Communications Co., Ltd.
2024-03-01
|
| Series: | Informatics and Health |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2949953423000012 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850223660395134976 |
|---|---|
| author | Dongping Gao Xiaoyao Wei Yuan Yang Ling Li Yan Qi Ran Zhang Ziyan Yuan Ranran Du Xiaobei Sun Huan Yin Yi Qin Hui Liu Jianwei Wang Chen Wang |
| author_facet | Dongping Gao Xiaoyao Wei Yuan Yang Ling Li Yan Qi Ran Zhang Ziyan Yuan Ranran Du Xiaobei Sun Huan Yin Yi Qin Hui Liu Jianwei Wang Chen Wang |
| author_sort | Dongping Gao |
| collection | DOAJ |
| description | Background: The selection of China annual major medical innovation organized by Chinese Academy of Medical Sciences (CAMS) has attracted increasing attention from the Chinese government and all sectors of society. It aims to explore a classification evaluation system that can reflect the characteristics of medical scientific and technological achievements, and advocate the proper value orientation of scientific and technological innovation. This study is the first public report on the selection process and results of China annual major medical innovation 2022. Methods: The selection of ''China annual major medical innovation 2022'' was supported by multidimensional data, and the quantitative evaluation of key analysis indicators was combined with peer expert review. It is the first time to put forward the inflection point calculation theory in individual academic domains and apply it to the evaluation of medical achievements, which shows the characteristics of each subject. The classification and evaluation were carried out according to the six medical domains of clinical medicine, stomatology, fundamental medicine and biology, pharmacology, public health and environment, and biomedical engineering and information. Results: The 31 major healthcare items were recognized in ''China annual major medical innovation 2022'', including 7 items in clinical medicine, 4 in stomatology, 8 in fundamental medicine and biology, 2 in pharmacology, 5 in public health and environment, and 5 in biomedical engineering and informatics. Conclusions: The selection of China annual major medical innovation has been organized and carried out by the CAMS for four consecutive years, and it is released once a year. The scientificity and credibility of the evaluation method and process have been continuously improved, bringing a certain social influence. At the same time, this study has a certain further space in the selection and weight design of key analysis indicators, the accuracy of the subject category for the results, the richness of the inflection point calculation theory in individual academic domains, and the scientific nature of multi-subject peer review. |
| format | Article |
| id | doaj-art-aa1f599f82a348d78cdb7c90be9982c4 |
| institution | OA Journals |
| issn | 2949-9534 |
| language | English |
| publishDate | 2024-03-01 |
| publisher | KeAi Communications Co., Ltd. |
| record_format | Article |
| series | Informatics and Health |
| spelling | doaj-art-aa1f599f82a348d78cdb7c90be9982c42025-08-20T02:05:51ZengKeAi Communications Co., Ltd.Informatics and Health2949-95342024-03-0111404810.1016/j.infoh.2023.08.001Analysis and Evaluation of China Annual Major Medical Innovation 2022: A Mix‐ Method Approach StudyDongping Gao0Xiaoyao Wei1Yuan Yang2Ling Li3Yan Qi4Ran Zhang5Ziyan Yuan6Ranran Du7Xiaobei Sun8Huan Yin9Yi Qin10Hui Liu11Jianwei Wang12Chen Wang13Institute of Medical Information, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100020, ChinaInstitute of Medical Information, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100020, ChinaInstitute of Medical Information, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100020, ChinaInstitute of Medical Information, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100020, ChinaInstitute of Medical Information, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100020, ChinaInstitute of Medical Information, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100020, ChinaInstitute of Medical Information, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100020, ChinaInstitute of Medical Information, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100020, ChinaInstitute of Medical Information, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100020, ChinaInstitute of Medical Information, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100020, ChinaInstitute of Medical Information, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100020, ChinaInstitute of Medical Information, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100020, China; Corresponding author.Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100006, ChinaChinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100006, ChinaBackground: The selection of China annual major medical innovation organized by Chinese Academy of Medical Sciences (CAMS) has attracted increasing attention from the Chinese government and all sectors of society. It aims to explore a classification evaluation system that can reflect the characteristics of medical scientific and technological achievements, and advocate the proper value orientation of scientific and technological innovation. This study is the first public report on the selection process and results of China annual major medical innovation 2022. Methods: The selection of ''China annual major medical innovation 2022'' was supported by multidimensional data, and the quantitative evaluation of key analysis indicators was combined with peer expert review. It is the first time to put forward the inflection point calculation theory in individual academic domains and apply it to the evaluation of medical achievements, which shows the characteristics of each subject. The classification and evaluation were carried out according to the six medical domains of clinical medicine, stomatology, fundamental medicine and biology, pharmacology, public health and environment, and biomedical engineering and information. Results: The 31 major healthcare items were recognized in ''China annual major medical innovation 2022'', including 7 items in clinical medicine, 4 in stomatology, 8 in fundamental medicine and biology, 2 in pharmacology, 5 in public health and environment, and 5 in biomedical engineering and informatics. Conclusions: The selection of China annual major medical innovation has been organized and carried out by the CAMS for four consecutive years, and it is released once a year. The scientificity and credibility of the evaluation method and process have been continuously improved, bringing a certain social influence. At the same time, this study has a certain further space in the selection and weight design of key analysis indicators, the accuracy of the subject category for the results, the richness of the inflection point calculation theory in individual academic domains, and the scientific nature of multi-subject peer review.http://www.sciencedirect.com/science/article/pii/S2949953423000012Medical advancementAnalysis and evaluationQuantitative evaluationQualitative evaluationInflection point calculation |
| spellingShingle | Dongping Gao Xiaoyao Wei Yuan Yang Ling Li Yan Qi Ran Zhang Ziyan Yuan Ranran Du Xiaobei Sun Huan Yin Yi Qin Hui Liu Jianwei Wang Chen Wang Analysis and Evaluation of China Annual Major Medical Innovation 2022: A Mix‐ Method Approach Study Informatics and Health Medical advancement Analysis and evaluation Quantitative evaluation Qualitative evaluation Inflection point calculation |
| title | Analysis and Evaluation of China Annual Major Medical Innovation 2022: A Mix‐ Method Approach Study |
| title_full | Analysis and Evaluation of China Annual Major Medical Innovation 2022: A Mix‐ Method Approach Study |
| title_fullStr | Analysis and Evaluation of China Annual Major Medical Innovation 2022: A Mix‐ Method Approach Study |
| title_full_unstemmed | Analysis and Evaluation of China Annual Major Medical Innovation 2022: A Mix‐ Method Approach Study |
| title_short | Analysis and Evaluation of China Annual Major Medical Innovation 2022: A Mix‐ Method Approach Study |
| title_sort | analysis and evaluation of china annual major medical innovation 2022 a mix method approach study |
| topic | Medical advancement Analysis and evaluation Quantitative evaluation Qualitative evaluation Inflection point calculation |
| url | http://www.sciencedirect.com/science/article/pii/S2949953423000012 |
| work_keys_str_mv | AT dongpinggao analysisandevaluationofchinaannualmajormedicalinnovation2022amixmethodapproachstudy AT xiaoyaowei analysisandevaluationofchinaannualmajormedicalinnovation2022amixmethodapproachstudy AT yuanyang analysisandevaluationofchinaannualmajormedicalinnovation2022amixmethodapproachstudy AT lingli analysisandevaluationofchinaannualmajormedicalinnovation2022amixmethodapproachstudy AT yanqi analysisandevaluationofchinaannualmajormedicalinnovation2022amixmethodapproachstudy AT ranzhang analysisandevaluationofchinaannualmajormedicalinnovation2022amixmethodapproachstudy AT ziyanyuan analysisandevaluationofchinaannualmajormedicalinnovation2022amixmethodapproachstudy AT ranrandu analysisandevaluationofchinaannualmajormedicalinnovation2022amixmethodapproachstudy AT xiaobeisun analysisandevaluationofchinaannualmajormedicalinnovation2022amixmethodapproachstudy AT huanyin analysisandevaluationofchinaannualmajormedicalinnovation2022amixmethodapproachstudy AT yiqin analysisandevaluationofchinaannualmajormedicalinnovation2022amixmethodapproachstudy AT huiliu analysisandevaluationofchinaannualmajormedicalinnovation2022amixmethodapproachstudy AT jianweiwang analysisandevaluationofchinaannualmajormedicalinnovation2022amixmethodapproachstudy AT chenwang analysisandevaluationofchinaannualmajormedicalinnovation2022amixmethodapproachstudy |